• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combined chelation therapy improves glucose metabolism in patients with beta-thalassaemia major.

作者信息

Christoforidis Athanasios, Perifanis Vassilios, Athanassiou-Metaxa Miranda

出版信息

Br J Haematol. 2006 Oct;135(2):271-2. doi: 10.1111/j.1365-2141.2006.06296.x. Epub 2006 Sep 11.

DOI:10.1111/j.1365-2141.2006.06296.x
PMID:16965387
Abstract
摘要

相似文献

1
Combined chelation therapy improves glucose metabolism in patients with beta-thalassaemia major.
Br J Haematol. 2006 Oct;135(2):271-2. doi: 10.1111/j.1365-2141.2006.06296.x. Epub 2006 Sep 11.
2
Glucose metabolism disorders improvement in patients with thalassaemia major after 24-36 months of intensive chelation therapy.重型地中海贫血患者经过24至36个月的强化螯合治疗后葡萄糖代谢紊乱情况得到改善。
Pediatr Endocrinol Rev. 2004 Dec;2 Suppl 2:279-81.
3
A new tool for the assessment of satisfaction with iron chelation therapy (ICT-Sat) for patients with β-thalassemia major.一种用于评估β-地中海贫血患者铁螯合治疗（ICT-Sat）满意度的新工具。
Pediatr Blood Cancer. 2012 Jun;58(6):910-5. doi: 10.1002/pbc.23413. Epub 2012 Jan 9.
4
Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator.
Br J Haematol. 2007 Aug;138(3):374-81. doi: 10.1111/j.1365-2141.2007.06651.x.
5
Iron chelation therapy in hereditary hemochromatosis and thalassemia intermedia: regulatory and non regulatory mechanisms of increased iron absorption [Kontoghiorghes GJ, Spyrou A, Kolganou A. Hemoglobin. 2010;34(3); 251-264].遗传性血色素沉着症和中间型地中海贫血中的铁螯合疗法：铁吸收增加的调节和非调节机制 [康托吉奥格斯 GJ, 斯皮鲁 A, 科尔加努 A. 《血红蛋白》. 2010 年;34(3);251 - 264]
Hemoglobin. 2011;35(2):175-9. doi: 10.3109/03630269.2011.557173.
6
Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.性腺功能减退、糖尿病、甲状腺功能减退、甲状旁腺功能减退：1980年至2007年在费拉拉中心随访的重型地中海贫血患者中与铁过载及螯合疗法相关的发病率和患病率
Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:158-69.
7
Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major.重型β地中海贫血输血周期中的非转铁蛋白结合铁
Ann N Y Acad Sci. 2005;1054:429-32. doi: 10.1196/annals.1345.074.
8
Glucose tolerance and beta-cell secretion in patients with thalassaemia major.
J Pediatr Endocrinol Metab. 1998;11 Suppl 3:985-6.
9
A new approach for potential combined chelation therapy using mono- and bis-hydroxypyridinones.一种使用单羟基吡啶酮和双羟基吡啶酮进行潜在联合螯合疗法的新方法。
Hemoglobin. 2008;32(1-2):147-56. doi: 10.1080/03630260701726939.
10
Iron chelating in thalassaemia with left ventricular dysfunction.地中海贫血合并左心室功能障碍时的铁螯合作用
Heart. 2006 Oct;92(10):1440. doi: 10.1136/hrt.2006.088377.

引用本文的文献

1
Risk Factors for Impaired Glucose Metabolism in Transfusion-Dependent Patients with β-Thalassemia: A Single-Center Retrospective Observational Study.输血依赖型β地中海贫血患者糖代谢受损的危险因素：一项单中心回顾性观察研究
Hematol Rep. 2025 Jan 30;17(1):6. doi: 10.3390/hematolrep17010006.
2
Endocrinopathies in beta thalassemia: a narrative review.β地中海贫血中的内分泌病：一项叙述性综述。
Hormones (Athens). 2024 Jun;23(2):205-216. doi: 10.1007/s42000-023-00515-w. Epub 2023 Dec 16.
3
Endocrinopathies in Hemoglobinopathies: What Is the Role of Iron?
血红蛋白病中的内分泌病：铁的作用是什么？
Int J Mol Sci. 2023 Nov 13;24(22):16263. doi: 10.3390/ijms242216263.
4
A Short Review on Growth and Endocrine Long-term Complications in Children and Adolescents with β-Thalassemia Major: Conventional Treatment versus Hematopoietic Stem Cell Transplantation.β-重型地中海贫血患儿和青少年的生长和内分泌长期并发症综述：常规治疗与造血干细胞移植。
Acta Biomed. 2022 Aug 31;93(4):e2022290. doi: 10.23750/abm.v93i4.13331.
5
The Pancreatic changes affecting glucose homeostasis in transfusion dependent β- thalassemia (TDT): a short review.影响输血依赖型β-地中海贫血（TDT）葡萄糖稳态的胰腺变化：简短综述。
Acta Biomed. 2021 Jul 1;92(3):e2021232. doi: 10.23750/abm.v92i3.11685.
6
The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients.重型地中海贫血患者葡萄糖稳态紊乱诊断与管理的ICET-A建议
Mediterr J Hematol Infect Dis. 2016 Oct 28;8(1):e2016058. doi: 10.4084/MJHID.2016.058. eCollection 2016.
7
Synthetic and natural iron chelators: therapeutic potential and clinical use.合成与天然铁螯合剂：治疗潜力与临床应用。
Future Med Chem. 2009 Dec;1(9):1643-70. doi: 10.4155/fmc.09.121.
8
Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.地中海贫血和中间型地中海贫血的心脏功能和铁螯合作用：对潜在病理生理学和螯合管理方法的综述。
Mediterr J Hematol Infect Dis. 2009 Jul 18;1(1):e2009002. doi: 10.4084/MJHID.2009.002.
9
The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management.当今输血依赖型纯合子地中海贫血患者的心脏——预测、预防与管理
Eur J Haematol. 2008 Feb;80(2):93-106. doi: 10.1111/j.1600-0609.2007.01018.x. Epub 2007 Dec 10.